Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9615 posts found.

Pfizer’s next blockbuster given FDA approval

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
News
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
News
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …
News
dementia

Director and location of £250 million UK Dementia Research Institute revealed

December 14, 2016 Medical Communications, Research and Development Alzheimer’s Research UK, Medical Research Council, alzheimer's research uk, alzheimer's society

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …
News
ritalin-sr-20mg-1000x1000

35% of all imported medicine in Guyana is fake, investigation finds

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …
News
new_york

New York in $500 million de Blasio-backed biotech boost

December 14, 2016 Manufacturing and Production, Research and Development New York, biotech, funding

Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …
News
actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
News
barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016 Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
News

Lilly offers insulin at 40% discount

December 13, 2016 Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
News

Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …
News
Press release
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
Appointment
emma-harvey0006_horizontal

Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases

December 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Feature
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016 Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
News
shutterstock_38078521

AZ and Lilly come together to battle Alzheimer’s

December 9, 2016 Research and Development, Sales and Marketing AZ, lilly

Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
News
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016 Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026